Nomura Initiates Inotek Pharmaceuticals At Buy

By: via Benzinga
Nomura initiated coverage on Inotek Pharmaceuticals Corporation (NASDAQ: ITEK) with a Buy rating. The target price for Inotek ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.